CL2004000726A1 - COMPOUNDS DERIVED FROM 4- [2- (REPLACED PHENYLOXY) PHENYL] PIPERIDINE OR -1,2,3,6-TETRAHYDROPIRIDINE; PHARMACEUTICAL COMPOSTION THAT CONTAINS THEM; AND ITS USE FOR THE TREATMENT OF AFFECTIVE DISORDERS, SUCH AS DEPRESSION, ANSIITY DISORDERS, ANSI - Google Patents

COMPOUNDS DERIVED FROM 4- [2- (REPLACED PHENYLOXY) PHENYL] PIPERIDINE OR -1,2,3,6-TETRAHYDROPIRIDINE; PHARMACEUTICAL COMPOSTION THAT CONTAINS THEM; AND ITS USE FOR THE TREATMENT OF AFFECTIVE DISORDERS, SUCH AS DEPRESSION, ANSIITY DISORDERS, ANSI

Info

Publication number
CL2004000726A1
CL2004000726A1 CL200400726A CL2004000726A CL2004000726A1 CL 2004000726 A1 CL2004000726 A1 CL 2004000726A1 CL 200400726 A CL200400726 A CL 200400726A CL 2004000726 A CL2004000726 A CL 2004000726A CL 2004000726 A1 CL2004000726 A1 CL 2004000726A1
Authority
CL
Chile
Prior art keywords
disorders
ansiity
tetrahydropiridine
phenyloxy
ansi
Prior art date
Application number
CL200400726A
Other languages
Spanish (es)
Inventor
Benny Kehler Jan Bang-Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36701494&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004000726(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of CL2004000726A1 publication Critical patent/CL2004000726A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CL200400726A 2003-04-04 2004-04-02 COMPOUNDS DERIVED FROM 4- [2- (REPLACED PHENYLOXY) PHENYL] PIPERIDINE OR -1,2,3,6-TETRAHYDROPIRIDINE; PHARMACEUTICAL COMPOSTION THAT CONTAINS THEM; AND ITS USE FOR THE TREATMENT OF AFFECTIVE DISORDERS, SUCH AS DEPRESSION, ANSIITY DISORDERS, ANSI CL2004000726A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300519 2003-04-04

Publications (1)

Publication Number Publication Date
CL2004000726A1 true CL2004000726A1 (en) 2005-05-20

Family

ID=36701494

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400726A CL2004000726A1 (en) 2003-04-04 2004-04-02 COMPOUNDS DERIVED FROM 4- [2- (REPLACED PHENYLOXY) PHENYL] PIPERIDINE OR -1,2,3,6-TETRAHYDROPIRIDINE; PHARMACEUTICAL COMPOSTION THAT CONTAINS THEM; AND ITS USE FOR THE TREATMENT OF AFFECTIVE DISORDERS, SUCH AS DEPRESSION, ANSIITY DISORDERS, ANSI

Country Status (8)

Country Link
KR (1) KR20050119682A (en)
CN (1) CN1767829A (en)
AR (1) AR043966A1 (en)
CL (1) CL2004000726A1 (en)
EA (1) EA009417B1 (en)
IS (1) IS7901A (en)
UA (1) UA81469C2 (en)
ZA (1) ZA200505031B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101613347B (en) * 2008-06-23 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 Amine compound and medical application thereof
WO2010056939A1 (en) * 2008-11-14 2010-05-20 Theravance, Inc. Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
CN104710345B (en) * 2013-12-17 2017-09-05 江苏恩华药业股份有限公司 For preparing 4(2‑(4 aminomethyl phenyl sulfenyls))Compound, its preparation method and the application of Phenylpiperidine
CN105348204B (en) * 2015-11-18 2018-09-14 乳源瑶族自治县大众药品贸易有限公司 1- heterocycles -2- (Heteroarylthio) benzene derivatives and its application method and purposes
CN105294554B (en) * 2015-11-18 2017-11-07 乳源瑶族自治县大众药品贸易有限公司 Phenylpiperazine derivatives and its application method and purposes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
IL149105A0 (en) * 1999-10-13 2002-11-10 Pfizer Prodcts Inc Biaryl ether derivatives useful as monoamine reuptake inhibitors
UA81749C2 (en) * 2001-10-04 2008-02-11 Х. Луннбек А/С Derivated of phenylpiperazine as serotonin reuptake inhibitorS

Also Published As

Publication number Publication date
EA009417B1 (en) 2007-12-28
UA81469C2 (en) 2008-01-10
ZA200505031B (en) 2006-09-27
KR20050119682A (en) 2005-12-21
IS7901A (en) 2005-06-20
AR043966A1 (en) 2005-08-17
CN1767829A (en) 2006-05-03
EA200501580A1 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
ECSP045004A (en) INHIBITORS OF THE 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3 FOR THE TREATMENT OF DEPENDING ANDROGEN DISEASES
UY28026A1 (en) 4-PIPERAZINILBENCENOSULFONILINDOLES AND USES OF THE SAME.
PA8575401A1 (en) DERIVATIVES OF BENZOCONDENSED HETEROARILAMIDE OF USEFUL TIENOPIRIDINS AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AND METHODS FOR USE
CR9667A (en) BENZAMIDA DERIVATIVES AND USES RELATED TO THE SAME
SV2006002134A (en) USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS REF. 5195-SV
PA8493701A1 (en) COMPOUNDS TO TREAT OBESITY
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034773A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
UY30314A1 (en) BENZONITRILE DERIVATIVES REPLACED WITH GLUCOPYRANOSIL, PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS OF THIS TYPE, USE AND PROCEDURE FOR MANUFACTURING
ECSP088283A (en) PIRIDINE COMPOUNDS 5- (PHENYLISOXAZOLILETOXI) -TRIAZOL- 3-ILO SUBSTITUTED FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
CL2012000033A1 (en) Compounds n- (3- (4as, 7as) -2-amino-4a, 5,7,7a-tetrahydro-4h-furo [3,4-d] [1,3] thiazin-7a-yl) -4- fluorophenyl) -5-fluoropiconylamide, bace inhibitor; pharmaceutical composition comprising them, use of the compound for the treatment of Alzheimer's disease.
PA8621901A1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
CO5271715A1 (en) 7-AZA-INDOLIN-2-WAVES SUBSTITUTED IN 4 AND ITS USE AS PROTEIUNA QUINASA INHIBITORS
NO20061122L (en) 2- (Quinoxaline-5-ylsuflonylamino) benzamide compounds as CCK2 modulators
UY31027A1 (en) DERIVATIVES OF TETRAHYDROINDOL AND TETRAHYDROINDAZOL
CL2008000795A1 (en) USE OF 1- [2- (2,4-DIMETILFENILSULFANIL) PHENYL) PIPERAZINE FOR THE TREATMENT OF PAIN OR RESIDUAL SYMPTOMS OF DEPRESSION; AND SUCH COMPOUND.
AR038047A1 (en) THERAPEUTIC AGENTS
CL2004000849A1 (en) COMPOUNDS DERIVED FROM BENZAMIDAS-2-HIDROXI-3-DIAMINOALCANS, USEFUL FOR THE TREATMENT OR PREVENTION OF ALZHEIMER, DOWN SYNDROME, HEREDITARY CEREBRAL HEMORRAGY, DEGENERATIVE DEMENCIES AND OTHERS.
BR0308653A (en) Glycopyranosyloxybenzyl benzene derivative crystals
UY30460A1 (en) THERAPEUTIC COMPOUNDS
GT200600163A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
GT200600161A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS
CU20090058A7 (en) PIRAZOLINE COMPOUNDS AND THEIR USE AND PHARMACEUTICAL COMPOSITIONS
ECSP066866A (en) DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS REFERENCE TO RELATED APPLICATIONS
ECSP045156A (en) INDOLILALQUILAMINE DERIVATIVES AS LIGANDOS 5-HIDROXITRIPTAMINA-6